Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
At age 50, you can make catch-up contributions to enhance your retirement savings. Understand how to take full advantage of this opportunity.
4,560 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A sharp 20% drop has many investors asking if PayPal stock is a bargain or a value trap. This guide breaks down the b...
Intuitive Machines has sparked a sharp turn in its stock without a major news release. This article breaks down why i...
A rising institutional move shines a light on how large managers deploy capital in broad market ETFs. This piece brea...
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...
If you’re hunting for a lifelong holding, the dividend track record of Medtronic is hard to ignore. This piece explai...
A new Nvidia platform called Vera Rubin could redefine AI economics for data centers. This piece breaks down what Ver...
A decade after her last album, Rihanna overtakes Taylor Swift in Spotify listenership, revealing lessons about catalo...
Royal Caribbean deploys AI to forecast demand, trim waste, and tailor guest experiences, signaling a data-driven shif...
Rising mortgage rates are reshaping how first-time buyers approach new homes. This article explains Meritage Homes’ f...
In volatile markets, a company that sells essential medical devices can offer stability and income. This guide explai...
A quarterly data snapshot reveals moves by the wealthiest fund managers. This piece dives into why these billionaire ...